About Cerimon Pharmaceuticals
Cerimon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to bringing innovative therapeutics to patients with substantial, unmet medical needs. The Company is engaged in the development and commercialization of therapeutics in the areas of autoimmune diseases, inflammation and pain. Cerimon was founded in November 2004 by Paul Sekhri, together with Ansbert Gadicke and Luke Evnin of MPM Capital, as a start-up biopharmaceutical company focused on innovative partnering deals with the pharmaceutical industry. Cerimon is headquartered in South San Francisco. For more information on Cerimon, please visit the Company's Website at http://www.cerimon.com .